We worked with AstraZeneca to optimise their chemical manufacturing processes, saving time and costs in large scale product production and manufacturing.
Simulation and machine learning for future medicine
We worked with AstraZeneca to accelerate lead optimisation by providing insights on a new class of drugs with the potential to reduce costs and increase productivity.
Using big data to streamline early stage drug development
We’re part of ADDoPT; an academic-industrial knowledge base collaboration with the UK pharmaceutical industry to accelerate advanced digital design techniques and streamline development.
Designing novel antimicrobial peptides
Ingenza is working with researchers based at the Hartree Centre on molecular simulation techniques with the potential to reduce the time and costs associated with bringing new drug designs to market.